Charite CCM Neurologie Berlin
Berlin, 10117, Germany
NCT Number: NCT01782365
The beneficial effect of nocturnal as well as daytime sleep on memory consolidation is well-documented in young, healthy subjects. Slow wave sleep (SWS), in particular, with its slow oscillating activity have shown to enhance declarative, hippocampus-dependent memory representations. This impact of sleep on memory performance can be additionally enhanced by exogeneous induction of transcranial slow oscillating stimulation (tSOS) within the frequency range of SWS in humans (0,7- 0,8 Hz) during sleep, as has been demonstrated in young, healthy subjects. If patients with amnestic mild cognitive impairment (MCI)- usually characterized by initial difficulties in hippocampus dependent memory functions - benefit from transcranial slow oscillatory stimulation (tSOS) during sleep as well has not been studied so far. The primary goal of the study is therefore to investigate the impact of oscillating current stimulation (tSOS) during a daytime nap on declarative memory consolidation in MCI patients.
Looking for future studies?
Notify Me50 year–90 year
All sexes
Interventional
Not applicable
Berlin, 10117, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
no stimulation
Other names: oscillating direct current brain stimulation
Time frame: 4 Weeks
Retention between stimulation conditions (0.75 Hz during SWS, vs sham stimulation during SWS) in the declarative memory task.
Time frame: 4 Weeks
Charite University, Berlin, Germany
Other
Impact of Transcranial Slow Oscillating Stimulation on Memory Consolidation During Slow Wave Sleep of a Daytime Nap in Patients With Mild Cognitive Impairment(MCI)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00422981
Brain Diseases, Central Nervous System Diseases
Peoria, Arizona, United States
View Trial DetailsNCT02417558
Cognition Disorders, Cognitive Dysfunction
View Trial DetailsNCT01684293
Cocaine Use Disorder, Cognition Disorders
San Francisco, California, United States
View Trial DetailsNCT03686839
Cognition Disorders, Cognitive Dysfunction
Paris, France
View Trial Details